1 recruiting, 1 terminated, 1 withdrawn. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Sabr: new trials by email Literature Review of Sabr trials Research Report on Sabr
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation Copper Cu 64-DOTA-pembrolizumab, Positron Emission Tomography, Stereotactic Body Radiation Therapy - Metastatic Malignant Solid Neoplasm | Early Phase 1 | Withdrawn | City of Hope Medical Center | 2023-08-25 | 2023-10-10 | |
| Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors Biospecimen Collection, Computed Tomography, Stereotactic Body Radiation Therapy - Metastatic Malignant Solid Neoplasm | Early Phase 1 | Recruiting | City of Hope Medical Center | 20 | 2023-04-27 | 2026-08-19 |
| Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer Laboratory Biomarker Analysis, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy - Stage I Non-Small Cell Lung Cancer AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 | Early Phase 1 | Terminated | Roswell Park Cancer Institute | 20 | 2017-12-18 | 2026-04-02 |
Neoplasm Metastasis (2) · Carcinoma, Non-Small-Cell Lung (1)
City of Hope Medical Center (2) · Roswell Park Cancer Institute (1)
United States (2)
Anurag Singh (1) · Sagus Sampath (1) · Yi-Jen Chen (1)
P30CA033572 (2)